These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
589 related articles for article (PubMed ID: 9570532)
1. Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation. Krasteva M; Kehren J; Horand F; Akiba H; Choquet G; Ducluzeau MT; Tédone R; Garrigue JL; Kaiserlian D; Nicolas JF J Immunol; 1998 Feb; 160(3):1181-90. PubMed ID: 9570532 [TBL] [Abstract][Full Text] [Related]
2. Lack of oral tolerance but oral priming for contact sensitivity to dinitrofluorobenzene in major histocompatibility complex class II-deficient mice and in CD4+ T cell-depleted mice. Desvignes C; Bour H; Nicolas JF; Kaiserlian D Eur J Immunol; 1996 Aug; 26(8):1756-61. PubMed ID: 8765017 [TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Bour H; Peyron E; Gaucherand M; Garrigue JL; Desvignes C; Kaiserlian D; Revillard JP; Nicolas JF Eur J Immunol; 1995 Nov; 25(11):3006-10. PubMed ID: 7489735 [TBL] [Abstract][Full Text] [Related]
4. MHC class II-KO mice are resistant to the immunosuppressive effects of UV light. Krasteva M; Aubin F; Laventurier S; Kehren J; Assossou O; Kanitakis J; Kaiserlian D; Nicolas JF Eur J Dermatol; 2002; 12(1):10-9. PubMed ID: 11809589 [TBL] [Abstract][Full Text] [Related]
5. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity. De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380 [TBL] [Abstract][Full Text] [Related]
6. Regulatory function of CD4+CD25+ T cells from Class II MHC-deficient mice in contact hypersensitivity responses. Kish DD; Gorbachev AV; Fairchild RL J Leukoc Biol; 2007 Jul; 82(1):85-92. PubMed ID: 17412917 [TBL] [Abstract][Full Text] [Related]
7. DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg. Han WG; Schuurhuis DH; Fu N; Camps M; van Duivenvoorde LM; Louis-Plence P; Franken KL; Huizinga TW; Melief CJ; Toes RE; Ossendorp F Eur J Immunol; 2009 Jul; 39(7):1765-73. PubMed ID: 19544486 [TBL] [Abstract][Full Text] [Related]
8. Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation. Hermans IF; Ritchie DS; Daish A; Yang J; Kehry MR; Ronchese F J Immunol; 1999 Jul; 163(1):77-81. PubMed ID: 10384102 [TBL] [Abstract][Full Text] [Related]
9. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft. Buonocore S; Flamand V; Goldman M; Braun MY Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166 [TBL] [Abstract][Full Text] [Related]
10. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes. Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194 [TBL] [Abstract][Full Text] [Related]
11. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice. Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222 [TBL] [Abstract][Full Text] [Related]
12. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504 [TBL] [Abstract][Full Text] [Related]
13. Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells. Asavaroengchai W; Kotera Y; Koike N; Pilon-Thomas S; Mulé JJ Biol Blood Marrow Transplant; 2004 Aug; 10(8):524-33. PubMed ID: 15282530 [TBL] [Abstract][Full Text] [Related]
14. Induction of antitumor immunity using bone marrow-generated dendritic cells. Porgador A; Snyder D; Gilboa E J Immunol; 1996 Apr; 156(8):2918-26. PubMed ID: 8609412 [TBL] [Abstract][Full Text] [Related]
15. Sequential role of plasmacytoid dendritic cells and regulatory T cells in oral tolerance. Dubois B; Joubert G; Gomez de Agüero M; Gouanvic M; Goubier A; Kaiserlian D Gastroenterology; 2009 Sep; 137(3):1019-28. PubMed ID: 19345221 [TBL] [Abstract][Full Text] [Related]
16. Active induction of unresponsiveness (tolerance) to DNFB by in vivo ultraviolet-exposed epidermal cells is dependent upon infiltrating class II MHC+ CD11bbright monocytic/macrophagic cells. Hammerberg C; Duraiswamy N; Cooper KD J Immunol; 1994 Dec; 153(11):4915-24. PubMed ID: 7963554 [TBL] [Abstract][Full Text] [Related]
17. Cross-reactive trinitrophenylated peptides as antigens for class II major histocompatibility complex-restricted T cells and inducers of contact sensitivity in mice. Limited T cell receptor repertoire. Kohler J; Martin S; Pflugfelder U; Ruh H; Vollmer J; Weltzien HU Eur J Immunol; 1995 Jan; 25(1):92-101. PubMed ID: 7843258 [TBL] [Abstract][Full Text] [Related]
18. Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo. Levin D; Constant S; Pasqualini T; Flavell R; Bottomly K J Immunol; 1993 Dec; 151(12):6742-50. PubMed ID: 7903097 [TBL] [Abstract][Full Text] [Related]
19. Switching from a restricted to an effective CD4 T cell response by activating CD8+ murine dendritic cells with a Toll-like receptor 9 ligand. Rizzitelli A; Vremec D; Villadangos JA; Mavaddat N; Wright MD; Shortman K Eur J Immunol; 2005 Nov; 35(11):3209-20. PubMed ID: 16224811 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF. Daro E; Butz E; Smith J; Teepe M; Maliszewski CR; McKenna HJ Cytokine; 2002 Feb; 17(3):119-30. PubMed ID: 11895330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]